CFNEWS – Dianosic in the press
https://dianosic.com/wp-content/uploads/2020/04/CFNEWS-test.jpg
540
250
Philippe Bastide
https://dianosic.com/wp-content/plugins/ultimate-member/assets/img/default_avatar.jpg
Le Journal des entreprises – Dianosic in the press
https://dianosic.com/wp-content/uploads/2020/04/Le-journal-des-entreprises-test.jpg
540
250
Philippe Bastide
https://dianosic.com/wp-content/plugins/ultimate-member/assets/img/default_avatar.jpg
-
Dianosic medtech raises funds to commercialize its first product.
- Click on the link to view the article
- Founded in July 2017, Dianosic medtech of Strasbourg has raised 1.5 million euros by completing its first round of financing. This sum is intended to accelerate the development and commercialization of its first two products for the treatment of diseases of the nasal cavity.
Dianosic closes first funding round of €1.5M
https://dianosic.com/wp-content/uploads/2020/04/Dianosic-test.jpg
540
250
Philippe Bastide
https://dianosic.com/wp-content/plugins/ultimate-member/assets/img/default_avatar.jpg
- ENT conditions start-up Dianosic closes first funding round of €1.5M
- First round of funding will enable Dianosic to support European launch of CAVI-T, its intranasal bleeding treatment device, and pursue development of disruptive solutions in treatment of chronic sinusitis.
- 1
- 2